
Overview
Nirav Shah, MD, MSHP, is an associate professor of medicine (hematology and oncology) at the Medical College of Wisconsin, specializing in lymphoma, CAR-T cell therapy, and stem cell transplant at Froedtert Hospital. He graduated with honors and Alpha Omega Alpha Honor Society membership from the University of Illinois at Chicago College of Medicine in 2008. He then completed his internal medicine residency at Massachusetts General Hospital in Boston, Massachusetts in 2011. Post-residency, he took a position at Northwestern Memorial Hospital in Hospitalist medicine before proceeding to the University of Pennsylvania where he completed both hematology/oncology fellowship and a Master’s degree in Health Policy research in 2015. His research focus is in the area of novel agents and cell therapy development for hematological malignancies. He is currently director of the Bone Marrow Transplant and Cellular Therapy Program at the Medical College of Wisconsin.
Dr. Shah is highly rated in 21 conditions, according to our data. His clinical expertise encompasses Marginal Zone Lymphoma (MZL), Large-Cell Immunoblastic Lymphoma, Diffuse Large B-Cell Lymphoma (DLBCL), Bone Marrow Transplant, and Bone Marrow Aspiration.
Dr. Shah is board certified in Hematology, Internal Medicine, and Medical Oncology. Dr. Shah is currently accepting new patients.
Specialties
Licenses
Board Certifications
Fellowships
Hospital Affiliations
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- HMO
- POS
- EPO
- HMO
- POS
- PPO
- EPO
- PPO
- EPO
- HMO
- PPO
- OTHER COMMERCIAL
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- POS
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MANAGED MEDICAID
- EPO
- HMO
- PPO
- OTHER MEDICAID
- STATE MEDICAID
- HMO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
8800 W. Doyne Ave., Milwaukee, WI 53226
Froedtert And The Medical College Of Wisconsin Froedtert Hospital
Timothy Fenske is a Hematologist practicing medicine in Milwaukee, Wisconsin. Dr. Fenske is highly rated in 28 conditions, according to our data. His clinical expertise encompasses Mantle Cell Lymphoma (MCL), Non-Hodgkin Lymphoma, B-Cell Lymphoma, Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Fenske is currently accepting new patients.
Froedtert Hospital
Dr. Joshua Field is an Associate Medical Director at the Versiti Blood Center of Wisconsin and an Assistant Professor of Medicine at the Medical College of Wisconsin. Dr. Field specializes in the treatment of sickle cell disease and other benign hematological disorders at Froedtert Hospital and Children’s Hospital of Wisconsin. Dr. Field graduated from the University of Iowa Medical School. He completed an Internal Medicine Residency and Fellowships in Hematology and Transfusion Medicine at Washington University in St. Louis, where he was Chief Resident in Internal Medicine and Chief Fellow in Hematology/Oncology. Dr. Field is Board Certified in Internal Medicine and Hematology. Dr. Field is highly rated in 16 conditions, according to our data. His clinical expertise encompasses Sickle Cell Disease, Hemoglobinopathy, Hemolytic Anemia, Congenital Hemolytic Anemia, and Bone Marrow Aspiration. Dr. Field is board certified in Hematology and Internal Medicine. Dr. Field is currently accepting new patients.
Clinical Cancer Center - Froedtert Hospital
Dr. Anita D’Souza is a professor of medicine (hematology/oncology). She completed her medical school from Goa Medical College, India where she graduated at the top of her class and was awarded Best Medical Graduate. She completed her internal medicine residency from William Beaumont Hospital in Michigan where she received the Zimmerman Award for Outstanding Clinical Judgment, Leadership, and Integrity. She completed her hematology/oncology fellowship from the Mayo Clinic in Rochester, Minnesota. She is a past recipient of the Daniel McCarty Award for Research Excellent and Women in Science Rising Pioneer Award at MCW. Dr. D'souza is highly rated in 15 conditions, according to our data. Her clinical expertise encompasses Multiple Myeloma, Primary Amyloidosis, Relapsed Refractory Multiple Myeloma (RRMM), Bone Marrow Transplant, and Tissue Biopsy. Dr. D'souza is board certified in Medical Oncology And Hematology and Internal Medicine. Dr. D'souza is currently accepting new patients.
Clinical Cancer Center - Froedtert Hospital
John Charlson is a Hematologist and an Oncologist practicing medicine in Milwaukee, Wisconsin. Dr. Charlson is highly rated in 30 conditions, according to our data. His clinical expertise encompasses Adult Soft Tissue Sarcoma, Liposarcoma, Synovial Sarcoma, and Undifferentiated Pleomorphic Sarcoma. Dr. Charlson is board certified in Medical Oncology. Dr. Charlson is currently accepting new patients.
Clinical Cancer Center - Froedtert Hospital
Binod Dhakal, MD, MS, is an associate professor of medicine (hematology and oncology) at the Medical College of Wisconsin, specializing in multiple myeloma and plasma cell disorders. He graduated from Manipal College of Medical Sciences, Pokhara Nepal in 2004, completed internal medicine residency at Saint Francis Hospital, Evanston, IL, and a fellowship in hematology/oncology at the Medical College of Wisconsin, where he also served as a chief fellow. Prior to joining the fellowship, he was an assistant professor of medicine (general internal medicine) at the Medical College in Wisconsin. He has authored numerous publications, including journal articles, meeting abstracts and book chapters. He has also won several awards during his fellowship which include the American Society of Clinical Oncology (ASCO) Merit Award; Medical College of Wisconsin Affiliated Hospitals (MCWAH) research award; Central Society for Clinical and Translational Research (CSCTR) best oral abstract and travel trainee award; American Society for Blood and Marrow Transplantation (ASBMT) clinical research training course; and, Outstanding Medical School Teacher award. Additionally, he was the recipient of the Mazie Froedtert Willms and Sue Froedtert Cancer Scholarship, and obtained his Master’s Degree in Clinical and Translational Science. His current research interests focus on novel drug treatments for patients with multiple myeloma and related plasma cell disorders by designing and conducting early phase clinical trials. Dr. Dhakal is highly rated in 11 conditions, according to our data. His clinical expertise encompasses Multiple Myeloma, Relapsed Refractory Multiple Myeloma (RRMM), Smoldering Multiple Myeloma, Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Dhakal is currently accepting new patients.
Clinical Cancer Center - Froedtert Hospital
Dr. Kurzrock is a world-renowned leader in precision oncology and rare cancers research. She is the Associate Director of Clinical Research for the Medical College of Wisconsin Cancer Center, Associate Director of Precision Oncology at the Linda T. and John A. Mellowes Center for Genomic Sciences and Precision Medicine and the founding director of the Michels Rare Cancers Research Laboratories at the MCW Cancer Center. She is recognized as one of the world’s 25 most important voices in precision medicine and one of the most highly cited scientists globally. She has authored over 950 scientific and medical publications. Dr. Kurzrock is the Chair for the Early Therapeutics and Rare Cancers Committee (SWOG NCI) — one of the largest clinical trials cooperative groups in the country — and has been the principal investigator for more than 100 early-phase clinical trials, leading eight life-changing drugs to FDA approval. In 2022, Dr. Kurzrock and the DART rare cancer study team received the National Cancer Institute Director’s Award of Merit for outstanding work. Dr. Kurzrock is highly rated in 35 conditions, according to our data. Her clinical expertise encompasses PIK3CA-Related Overgrowth Spectrum, Castleman Disease, Multicentric Castleman Disease (MCD), Lymphoid Hyperplasia, and Tissue Biopsy. Dr. Kurzrock is board certified in Internal Medicine and Medical Oncology. Dr. Kurzrock is currently accepting new patients.
Frequently Asked Questions about Dr. Nirav N. Shah
How do I make an appointment with Dr. Nirav N. Shah?
You can book an appointment with Dr. Nirav N. Shah by calling their office at 414-805-0505. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Nirav N. Shah a top-rated expert for Marginal Zone Lymphoma (MZL)?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Nirav N. Shah is classified as an Distinguished expert for Marginal Zone Lymphoma (MZL), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Nirav N. Shah specialize in?
While Dr. Nirav N. Shah is a Hematology, they have specific expertise in Marginal Zone Lymphoma (MZL), Large-Cell Immunoblastic Lymphoma, and Diffuse Large B-Cell Lymphoma (DLBCL). MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Hematology.
Does Dr. Nirav N. Shah accept my insurance?
Dr. Nirav N. Shah accepts most major insurance plans, including Anthem BCBS and Aspirus Arise Health. We recommend calling the office directly at 414-805-0505 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Chronic Familial NeutropeniaDr. Shah isDistinguished. Learn about Chronic Familial Neutropenia.
- Diffuse Large B-Cell Lymphoma (DLBCL)Dr. Shah isDistinguished. Learn about Diffuse Large B-Cell Lymphoma (DLBCL).
- Large-Cell Immunoblastic LymphomaDr. Shah isDistinguished. Learn about Large-Cell Immunoblastic Lymphoma.
- Marginal Zone Lymphoma (MZL)Dr. Shah isDistinguished. Learn about Marginal Zone Lymphoma (MZL).
- Advanced
- Acute Myeloblastic Leukemia with Maturation
- Acute Myeloblastic Leukemia without Maturation
- Acute Myeloid Leukemia (AML)Dr. Shah isAdvanced. Learn about Acute Myeloid Leukemia (AML).
- B-Cell LymphomaDr. Shah isAdvanced. Learn about B-Cell Lymphoma.
- Bone Marrow TransplantDr. Shah isAdvanced. Learn about Bone Marrow Transplant.
- Childhood Acute Myeloid Leukemia
- Chronic Myelomonocytic Leukemia (CMML)
- Classical Hodgkin LymphomaDr. Shah isAdvanced. Learn about Classical Hodgkin Lymphoma.
- Follicular LymphomaDr. Shah isAdvanced. Learn about Follicular Lymphoma.
- Gastric LymphomaDr. Shah isAdvanced. Learn about Gastric Lymphoma.
- Hodgkin LymphomaDr. Shah isAdvanced. Learn about Hodgkin Lymphoma.
- Mantle Cell Lymphoma (MCL)Dr. Shah isAdvanced. Learn about Mantle Cell Lymphoma (MCL).
- Multiple MyelomaDr. Shah isAdvanced. Learn about Multiple Myeloma.
- Myelodysplastic Syndrome (MDS)
- Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL)
- Non-Hodgkin LymphomaDr. Shah isAdvanced. Learn about Non-Hodgkin Lymphoma.
- Primary Lymphoma of the BrainDr. Shah isAdvanced. Learn about Primary Lymphoma of the Brain.
- Experienced
- Acute Lymphoblastic Leukemia (ALL)Dr. Shah isExperienced. Learn about Acute Lymphoblastic Leukemia (ALL).
- Acute Monoblastic Leukemia (AmoL)Dr. Shah isExperienced. Learn about Acute Monoblastic Leukemia (AmoL).
- AgranulocytosisDr. Shah isExperienced. Learn about Agranulocytosis.
- Bone Marrow AspirationDr. Shah isExperienced. Learn about Bone Marrow Aspiration.
- Burkitt LymphomaDr. Shah isExperienced. Learn about Burkitt Lymphoma.
- Chronic B-Cell Leukemia (CBCL)Dr. Shah isExperienced. Learn about Chronic B-Cell Leukemia (CBCL).
- Chronic Graft Versus Host Disease (cGvHD)
- Chronic Lymphocytic Leukemia (CLL)Dr. Shah isExperienced. Learn about Chronic Lymphocytic Leukemia (CLL).
- Chronic Myelogenous Leukemia (CML)Dr. Shah isExperienced. Learn about Chronic Myelogenous Leukemia (CML).
- Cyclic NeutropeniaDr. Shah isExperienced. Learn about Cyclic Neutropenia.
- Febrile NeutropeniaDr. Shah isExperienced. Learn about Febrile Neutropenia.
- Graft Versus Host Disease (GvHD)Dr. Shah isExperienced. Learn about Graft Versus Host Disease (GvHD).
- Hemophagocytic LymphohistiocytosisDr. Shah isExperienced. Learn about Hemophagocytic Lymphohistiocytosis.
- Myeloproliferative Neoplasms (MPN)Dr. Shah isExperienced. Learn about Myeloproliferative Neoplasms (MPN).
- Philadelphia-Negative Chronic Myeloid Leukemia
- POEMS SyndromeDr. Shah isExperienced. Learn about POEMS Syndrome.
- Prolymphocytic LeukemiaDr. Shah isExperienced. Learn about Prolymphocytic Leukemia.
- Relapsed Refractory Multiple Myeloma (RRMM)
- Richter SyndromeDr. Shah isExperienced. Learn about Richter Syndrome.
- Severe Congenital NeutropeniaDr. Shah isExperienced. Learn about Severe Congenital Neutropenia.
- Small Lymphocytic Lymphoma (SLL)Dr. Shah isExperienced. Learn about Small Lymphocytic Lymphoma (SLL).
- Smoldering Multiple MyelomaDr. Shah isExperienced. Learn about Smoldering Multiple Myeloma.
- Virus Associated Hemophagocytic Syndrome
- Waldenstrom MacroglobulinemiaDr. Shah isExperienced. Learn about Waldenstrom Macroglobulinemia.




